Collegium Pharmaceutical (COLL) Free Cash Flow (2014 - 2026)

Collegium Pharmaceutical's Free Cash Flow history runs 13 years deep, the most recent figure standing at $56.8 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 4.11% year-over-year to $56.8 million; the TTM figure through Mar 2026 stood at $331.2 million (up 68.52% YoY), while the FY2025 annual figure was $329.0 million, up 61.81% from the prior year.
• Free Cash Flow was $56.8 million for Q1 2026 at Collegium Pharmaceutical, down from $123.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $123.0 million in Q4 2025 to a low of -$25.4 million in Q1 2022.
• Historically, Free Cash Flow has averaged $58.0 million across 5 years, with a median of $65.4 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 226.22% in 2022, then surged 891.9% in 2025.
• A 5-year view of Free Cash Flow shows it stood at $65.4 million in 2022, then grew by 11.91% to $73.2 million in 2023, then advanced by 14.9% to $84.1 million in 2024, then jumped by 46.35% to $123.0 million in 2025, then slumped by 53.8% to $56.8 million in 2026.
• The last three Free Cash Flow figures came in at $56.8 million (Q1 2026), $123.0 million (Q4 2025), and $78.2 million (Q3 2025), per Business Quant data.